Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers

详细信息    查看全文

• 作者：Hellas Cena (1)
  Antonella Tesone (1)
  Rosanna Niniano (2)
  Isa Cerveri (2)
  Carla Roggi (1)
  Giovanna Turconi (1)
  
• 关键词：Metabolic syndrome ; Smoking habit ; Insulin resistance ; Overweight ; Waist circumference
• 刊名：Diabetology and Metabolic Syndrome
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：5
• 期：1
• 全文大小：198KB
• 参考文献：1. World Health Organization: Tobacco free initiative: Why is tobacco a public health priority. Available at: http://www.who.int/tobacco/health_priority/en/ Accessed on January 31, 2011
  2. Frati AC, Iniestra F, Ariza CR: Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. / Diabetes Care 1996, 19:112-18. CrossRef
  3. Targher G, Alberiche M, Zenere MB, / et al.: Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. / J Clin Endocrinol Metab 1997, 82:3619-624. CrossRef
  4. Wada T, Urashima M, Fukumoto T: Risk of metabolic syndrome persists twenty years after the cessation of smoking. / Intern Med 2007, 46:1079-082. CrossRef
  5. Lee WY, Jung CH, Park JS, / et al.: Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. / Diabetes Res Clin Pract 2005, 67:70-7. CrossRef
  6. Tsiara S, Elisaf M, Mikhailidis DP: Influence of smoking on predictors of vascular disease. / Angiology 2003, 54:507-30. CrossRef
  7. Steiner G, Schwartz L, Shumak S, / et al.: The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. / Circulation 1987, 75:124-30. CrossRef
  8. Criqui MH, Wallace RB, Heiss G, / et al.: Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. / Circulation 1980, 62:IV70-IV76.
  9. Cena H, Fonte ML, Turconi G: Relationship between smoking and Metabolic Syndrome. / Nutr Rev 2011,69(12):745-53. CrossRef
  10. Miyatake N, Wada J, Kawasaki Y, / et al.: Relationship between metabolic syndrome and cigarette smoking in the Japanese population. / Intern Med 2006, 45:1039-043. CrossRef
  11. Geslain-Biquez C, Vol S, Tichet J, / et al.: The metabolic syndrome in smokers. The D.E.S.I.R. study. / Diabetes Metab 2003, 29:226-34. CrossRef
  12. Weitzman M, Cook S, Auinger P, / et al.: Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. / Circulation 2005, 112:862-69. CrossRef
  13. Saarni SE, Pietilainen K, Kantonen S, / et al.: Association of smoking in adolescence with abdominal obesity in adulthood: a follow-up study of 5 birth cohorts of Finnish twins. / Am J Public Health 2009, 99:348-54. CrossRef
  14. Kawada T, Otsuka T, Inagaki H, / et al.: Association of smoking status, insulin resistance, body mass index, and metabolic syndrome in workers: a 1-year follow-up study. / Obes Res Clin Pract 2010, 4:e163-e169. CrossRef
  15. Reaven G, Tsao PS: Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? / J Am Coll Cardiol 2003, 41:1044-047. CrossRef
  16. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. / Br J Nutr 1974,32(1):77-7. CrossRef
  17. Li Y, Swensen SJ, Karabekmez LG, / et al.: Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography-based Assessment. / Cancer Prev Res 2011,4(1):43-0. CrossRef
  18. Forey BA, Thornton AJ, Lee PN: Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. / BMC Pulm Med 2011, 11:36. CrossRef
  19. Assmann G, Guerra R, Fox G, / et al.: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. / Am J Cardiol 2007, 99:541-48. CrossRef
  20. Alberti KG, Eckel RH, Grundy SM, National Heart, Lung, and Blood Institute, / et al.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. / Circulation 2009, 120:1640-645. CrossRef
  21. Alberti KG, Zimmet P: Shaw Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. / J Diabetes Med 2006,23(5):469-80. CrossRef
  22. Ford ES, Li C, Zhao G: Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. / J Diabetes 2010,2(3):180-93. CrossRef
  23. Grundy SM, Cleeman JI, Daniels SR, / et al.: American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. / Circulation 2005,112(17):2735-752. CrossRef
  24. Hayes L, Pearce MS, Unwin NC: Lifecourse predictors of normal metabolic parameters in overweight and obese adults. / Int J Obes 2006,30(6):970-76. CrossRef
  25. Wannamethee SG, Shaper AG, Whincup PH: Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes. / J Am Geriatr Soc 2006,54(12):1909-914. CrossRef
  26. Zhu S, St-Onge MP, Heshka S, / et al.: Lifestyle Behaviors associeted with lower risk of having the Metabolic Syndrome. / Metabolism 2004,53(11):1503-511. CrossRef
  27. Pinto Pereira SM, Ki M, Power C: Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work. / PLoS One 2012,7(2):e31132. CrossRef
  28. Tankó LB, Christiansen C: An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. / Menopause 2004,11(1):104-09. CrossRef
  29. Kwok S, Canoy D, Soran H, / et al.: Body fat distribution in relation to smoking and exogenous hormones in British women. / Clin Endocrinol 2011.
  30. Clair C, Chiolero A, Faeh D, / et al.: Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based survey. / BMC Public Health 2011, 11:23. CrossRef
  31. Chiolero A, Faeh D, Paccaud F, / et al.: Consequences of smoking for body weight, body fat distribution, and insulin resistance. / Am J Clin Nutr 2008,87(4):801-09.
  32. Shimokata H, Muller DC, Andres R: Studies in the distribution of body fat. Effects of cigarettes smoking. / JAMA 1989, 26:1169-173. CrossRef
  33. Kishida K, Funahashi T, Matsuzawa Y, / et al.: Visceral adiposity as a target for the management of the metabolic syndrome. / Ann Med 2011,44(3):233-41. CrossRef
  34. Petursson H, Sigurdsson JA, Bengtsson C, / et al.: Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. / PLoS One 2011,6(10):e26621. CrossRef
  35. Will JC, Galuska DA, Ford ES, / et al.: Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. / Int J Epidemiol 2001,30(3):540-46. CrossRef
  36. Tanko LB: Novel association between bioaviable estradiol and adipokines in ederlywomen with different phenotypes of obesity: implication for atherogenesis. / Circulation 2004,110(15):2246-252. CrossRef
  37. Cryer PE, Haymond MW, Santiago JV, / et al.: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. / N Engl J Med 1976,295(11):573-77. CrossRef
  38. Kannel WB: Cigarettes, coronary occlusion, and myocardial infarction. / JAMA 1981,246(8):871-72. CrossRef
  39. Beaser RS, Levy P: Metabolic syndrome: a work in progress, but a useful construct. / Circulation 2007, 115:1812-818. CrossRef
  40. Eliasson B, Attvall S, Taskinen MR, / et al.: The insulin resistance syndrome in smokers is related to smoking habits. / Arterioscler Thromb 1994,14(12):1946-950. CrossRef
  41. Barter P: Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. / Atheroscler Suppl 2011,12(3):265-66. CrossRef
  42. Kontush A, Chapman MJ: Antiatherogenic small, dense HDL–guardian angel of the arterial wall? / Nat Clin Pract Cardiovasc Med 2006,3(3):144-53. CrossRef
  43. Graham I, Atar D, Borch-Johnsen K, / et al.: European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies. / Eur J Cardiovasc Prev Rehabil 2007,14(Suppl. 2):S1-S113. CrossRef
  44. Alberico L, The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Authors/Task Force Members, / et al.: Review et ESC/EAS Guidelines for the management of dyslipidaemias. / Atherosclerosis 2011, 217S:S1-S44.
  45. Travier N, Agudo A, May A, / et al.: Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. / Prev Med 2012,54(3-):183-92. CrossRef
  46. Katano S, Nakamura Y, Nakamura A, / et al.: Relationship among phisycal activity, smoking, drinking and clustering of the Metabolic Syndrome Diagnostic Components. / J Atheroscler Thromb 2010,17(6):644-50. CrossRef
  47. Kleppinger A, Litt MD, Kenny AM, / et al.: Effects of smoking cessation on body composition in postmenopausal women. / J Womens Health 2010,19(9):1651-657. CrossRef
  48. Gorber SC, Tremblay M, Moher D, / et al.: A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. / Obes Rev 2007,8(4):307-26. CrossRef
  
• 作者单位：Hellas Cena (1)
  Antonella Tesone (1)
  Rosanna Niniano (2)
  Isa Cerveri (2)
  Carla Roggi (1)
  Giovanna Turconi (1)
  
  1. Department of Public Health, Experimental and Forensic Medicine, Section of Human Nutrition, University of Pavia, Via Bassi 21, 27100, Pavia, Italy
  2. Respiratory Pathophysiology Unit, Policlinico San Matteo IRCCS, Viale Golgi, 19, 27100, Pavia, Italy
  

文摘

Background Smoking is an important cause of morbidity and mortality worldwide. It is widely accepted as a major risk factor for metabolic and cardiovascular disease. Smoking reduces insulin sensitivity or induces insulin resistance and enhances cardiovascular risk factors such as elevated plasma triglycerides, decreases high-density lipoprotein cholesterol and causes hyperglycemia. Several studies show that smoking is associated with metabolic abnormalities and increases the risk of Metabolic Syndrome. The aim of this study was to estimate the prevalence of the metabolic syndrome in a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined the smoking cessation program held by the Respiratory Pathophysiology Unit of San Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and had no cancer or psychiatric disorders, nor history of diabetes or CVD or coronary artery disease and were not on any medication. Results The subjects smoke 32.3?±-6.5 mean Pack Years. The prevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males and females respectively. Analysing the smoking habit influence on the IDF criteria for the metabolic syndrome diagnosis we found that all the variables show an increasing trend from light to heavy smokers, except for HDL cholesterol. A statistical significant correlation among Pack Years and waist circumference (R--.48, p-lt;-.0001), Systolic Blood Pressure (R--.18, p-lt;-.05), fasting plasma glucose (R--.19, p-lt;-.005) and HDL cholesterol (R-??0.26, p--.0005) has been observed. Conclusions Currently smoking subjects are at high risk of developing the metabolic syndrome. Therapeutic lifestyle changes, including smoking cessation are a desirable Public health goal and should successfully be implemented in clinical practice at any age.